Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Al/ML Data sets
new
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease
FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease
IO Biotech Announces
IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
Sanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share purchase agreement with buyer Clayton Dubilier & Rice (CD&R).
Japan’s MHLW approves CSL Behring’s Andembry to stop HAE attacks
CSL Behring KK has gained approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) to manufacture and market subcutaneous (SC) injection 200mg Andembry (Garadacimab...
FDA Grants Fast Track Status to SIGX1094
FDA Grants Fast Track Status to SIGX1094 for Diffuse Gastric Cancer
Thetis Pharmaceuticals Presents New Preclinical and Clinical Data for TP-317 at ECCO 2025
Thetis Pharmaceuticals Presents New Preclinical and Clinical Data for TP-317 at ECCO 2025
Japanese researchers enhance mRNA
Japanese researchers enhance mRNA cancer drugs' protein synthesis efficiency by 200 times
Telomir Pharmaceuticals announces results from preclinical studies of Telomir-1
Telomir Pharmaceuticals announced results from its recent preclinical studies conducted in human retinal cell lines. These studies demonstrated the ability of Telomir-1 to significantly rev...
Innate’s lacutamab gains FDA breakthrough therapy designation
Innate’s lacutamab gains FDA breakthrough therapy designation
FDA grants Fast Track Status to Rznomics’
FDA grants Fast Track Status to Rznomics’ RZ-001 for the treatment of hepatocellular carcinoma
Drug Discovery Preclinical CRO
Drug Discovery Preclinical CRO Market Growth Accelerating at 6.17% CAGR to 30.5 Billion USD by 2032
GSK’s
GSK’s Penmenvy meningococcal vaccine gains FDA approval
6
7
8
9
10
11
12
13
14
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Al/ML Data sets
Synthetic and Medicinal Chemistry
In silico drug design (CADD)
Discovery biology
ADME, DMPK
Functional ex vivo and in vivo models
Safety and Toxicology
Company
News & Media
Contact us
Trends in discovery compounds